###### Strengths and limitations of this study

-   Strengths of our study include its large sample and the use of a validated population-based rheumatoid arthritis (RA) cohort.

-   Our main limitation is that our cohort definition requires patients whose family physician strongly suspects that the patient has RA; thus, our analyses are likely restricted to patients with a more homogeneous clinical presentation (such as rheumatoid factor positive patients) or those with more active disease.

-   Owing to the absence of symptom onset and date of referral in health administrative databases, we have only studied a proportion of the total delay to rheumatology consultations.

Rheumatoid arthritis (RA) is a progressive inflammatory arthritis associated with joint damage and functional deterioration, work disability and premature mortality.[@R1] At disease onset, RA is considered as an urgent medical condition[@R1] [@R2] requiring prompt referral to a rheumatologist.[@R3] Timely rheumatology care is important as it increases early exposure to treatment,[@R6] improves patient outcomes,[@R7] [@R8] decreases the need for costly surgical interventions[@R9] and thus reduces the global disease burden. Furthermore, the sooner a patient is seen and managed by rheumatologists results in superior clinical responses and increases the chance of disease remission[@R10] than if the same care is administered later in the disease course.[@R15]

In Canada, access to specialists often depends on referral by a family physician. For optimal RA care to occur, a patient must seek care by a family physician, who, in turn, must suspect RA and initiate referral to a rheumatologist, who will undertake the appropriate diagnostic tests and initiate early treatment.[@R16] Delays that occur at any of these stages prevent patients from receiving timely care.

Ontario has approximately 13 million residents and 10 000 family physicians.[@R17] There are approximately 150 rheumatologists (1.5 rheumatologists per 100 000 population); however, they are concentrated most heavily in southern Ontario,[@R18] which may be a potential barrier to equitable, timely rheumatology care.[@R19] Accordingly, we set out to determine the percentage of patients with incident RA who consulted a rheumatologist within 3, 6 and 12 months of suspected diagnosis by a family physician, and assessed what factors may influence the time frame within which patients are seen.

Subjects and methods {#s1}
====================

Setting and design {#s1a}
------------------

We performed a retrospective, population-based cohort study of newly diagnosed patients with RA within Ontario, in which all residents are covered by universal public health insurance for physician and hospital services.

Data sources {#s1b}
------------

We used the Ontario Rheumatoid Arthritis Administrative Database (ORAD), a population-based RA cohort generated from health administrative databases using a validated case definition. Patients with RA are included in ORAD if they have three Ontario Health Insurance (OHIP) physician service claims over a 2-year period in which RA is the recorded diagnosis, with at least one of these claims made by a musculoskeletal specialist. ORAD has been validated and shown to have a high sensitivity (78%), specificity (100%) and positive predictive value (78%) for identifying patients with RA based on medical record reviews.[@R20] [@R21] Validation of RA onset within administrative data has also shown to be highly accurate.[@R21] Records for individuals in ORAD are also linked to the following administrative datasets. The Ontario Registered Persons Database was used to identify demographic information on age, sex, place of residence, death and emigration. Physician specialty was obtained by linking the Institute for Clinical Evaluative Sciences (ICES) Physician Database with the OHIP database.[@R22] We used the Client Agency Program Enrolment Database to identify the primary care delivery model of the family physician at the time the patient entered the cohort. These datasets are linked in an anonymous fashion using encrypted health insurance numbers for residents and encrypted license numbers for physicians, and they have very little missing information.[@R23]

Cohort definition {#s1c}
-----------------

We identified all incident patients with RA from 1 April 2000 to 31 March 2010. Analyses were restricted to patients whose initial RA diagnosis codes were assigned by a family physician in an outpatient setting. Cohort entry (suspected RA diagnosis date) was the date of the first RA diagnosis code, and patients were followed up until 1 year or until outmigration, death or the end of study period.

Covariate information {#s1d}
---------------------

Covariates for patient demographics included age, sex, socioeconomic status (SES) and year of suspected diagnosis. SES was defined as the patient\'s neighbourhood median household income quintile from the Statistics Canada Census. We also identified whether patients were subsequently admitted to hospital with an RA diagnosis following a primary care diagnosis, as patients who are seen in a hospital setting for their RA may have poorer access to healthcare providers and/or more severe disease. As a measure of comorbidity, we used the Johns Hopkins Adjusted Diagnostic Groups (ADG) Case-Mix System derived from outpatient and inpatient data in 2 years preceding cohort entry.[@R24] We categorised ADGs into low (\<5), moderate (5--9) and high comorbidity (10+). We chose this risk adjustment method as patients using the most healthcare resources are not typically those with single diseases but rather those with multiple and sometimes unrelated conditions. This clustering of morbidity can be a better predictor of healthcare use than the presence of specific diseases.[@R25] Geographical characteristics included patient residence, regional health service planning areas (Local Health Integration Networks, LHINs[@R26]), rheumatology supply and distance to the closest rheumatologist. Rurality was based on each patient\'s postal code and a community population size of less than 10 000. Rheumatology supply was defined as the number of rheumatologists per 100 000 adults in the planning area (LHIN) of patient residence, and distance to the closest rheumatologist was the linear distance from the centre of patient\'s postal code area to that of the closest rheumatologist, with 'remote residence' defined as 100 or more kilometres to the nearest rheumatologist. Family physician characteristics included sex, years since graduation (as a proxy for experience) and type of primary care delivery model the family physician was working in at the time of patient\'s cohort entry. We categorised each practice type as (1) *blended capitation models* (Family Health Networks (FHNs), Family Health Organisations (FHOs), Family Health Teams (FHTs)) and (2) either traditional or enhanced fee-for-service models (Family Health Groups or FHGs).[@R27] The main difference between the models is how physicians are reimbursed (eg, through age-adjusted and sex-adjusted capitation payments versus being paid on a per visit basis). Capitation models often include interdisciplinary teams involving allied healthcare providers and require physicians to maintain a list or 'roster' of enrolled patients to whom they are committed to providing primary care.[@R28] Including primary care model type enabled us to explore if there was an effect regarding different primary care practice models and/or how the physicians are paid as a facilitator to timely rheumatology care.

Outcome measurements {#s1e}
--------------------

We followed incident patients, determining whether they had a visit to a rheumatologist at 3, 6 and 12 months of cohort entry.

Statistical analysis {#s1f}
--------------------

Descriptive statistics were used to characterise the study population. We assessed secular trends (as the percentage of each annual incident RA cohort who consulted a rheumatologist within each time period) and differences among patients who received versus did not receive rheumatology care. We performed hierarchical logistic regression analyses to determine whether receipt of rheumatology care was associated with patient demographics, comorbidity, geographical characteristics and family physician characteristics. Crude and adjusted OR (aOR) estimates with 95% CIs were generated. Separate analyses were performed for each outcome end date (benchmarks): 3, 6 and 12 months.

All analyses were performed at the ICES on anonymised data using SAS V.9.2 (SAS Institute, Cary, North Carolina, USA).

Results {#s2}
=======

Between 2000 and 2009, we identified 19 670 patients with incident RA ([figure 1](#BMJOPEN2013003888F1){ref-type="fig"}). Overall, the mean (SD) age at the time of cohort entry was 54 (16) years, 71% were women, 16% resided in rural areas and 5% resided in areas remote (≥100 km) from the nearest rheumatologist ([table 1](#BMJOPEN2013003888TB1){ref-type="table"}). Most patients were seen by male family physicians (70%). Few (5%) physicians were practising under a newer capitation model.

###### 

Selected cohort characteristics of 19 670 newly diagnosed patients with RA that met our criteria

  Characteristic                                                                       Newly diagnosed RA n=19 670
  ------------------------------------------------------------------------------------ -----------------------------
  Patient demographics                                                                 
   Age at cohort entry, mean (SD)                                                      53.7 (16.3)
   Female, n (%)                                                                       14 091 (71.1)
   Rural residence, n (%)                                                              3196 (16.2)
  Patient comorbidity                                                                  
   Number of Hopkins ADGs\* in the 2 years prior to entry, n (%)                       
    \<5                                                                                5229 (26.5)
    5--9                                                                               9790 (49.5)
    10+                                                                                4741 (24.0)
  Rheumatology access measures                                                         
   Time (days) from first diagnosis code to first rheumatologist visit, mean (SD)      76.7 (76.9)
   Time (days) from first diagnosis code to first rheumatologist visit, median (IQR)   50 (22--104)
   Rheumatology supply per 100 000 adults†, mean (SD)                                  1.5 (1.1)
  Distance to closest rheumatologist                                                   
   Kilometres, mean (SD)                                                               24.2 (69.7)
   Remote (≥100 km), n (%)                                                             1047 (5.3)
  Primary care physician\'s characteristics                                            
   Male, n (%)                                                                          13 872 (70.2)
   Years since graduation, mean (SD)                                                   24.5 (10.5)
  Practice type, n (%)                                                                 
   Blended capitation models‡ (FHO/FHN)                                                976 (4.9)
   Traditional fee-for-service and enhanced fee-for-service (FHG/other)                18 784 (95.1)

\*Ambulatory diagnostic groups.

†In patient LHINs (regional health service planning areas).

‡Practice types: *blended capitation models* (FHNs, FHOs, FHTs, an interprofessional team model composed of FHNs and FHOs), *enhanced fee-for-service models* (FHGs and other groups).

ADG, Adjusted Diagnostic Groups; FGH, Family Health Group; FHN, Family Health Network; FHO, Family Health Organisation; FHT, Family Health Team; LHIN, Local Health Integration Network; RA, rheumatoid arthritis.

![Flow diagram of selection of study participants.](bmjopen2013003888f01){#BMJOPEN2013003888F1}

Over 1 year of follow-up, the average time from the first RA diagnosis code to first rheumatologist visit was 77 days ([table 1](#BMJOPEN2013003888TB1){ref-type="table"}). Overall, 59%, 75% and 84% of patients consulted a rheumatologist within 3, 6 and 12 months, respectively. The prevalence of initial rheumatology encounters within 3 months did not increase over the study period. However, the percentage of patients who consulted a rheumatologist within 6 and 12 months increased gradually over time, from 72% and 81% in 2000 to 81% and 89% in 2009, respectively ([figure 2](#BMJOPEN2013003888F2){ref-type="fig"}).

![Percentage of patients with newly diagnosed rheumatoid arthritis who are seen by a rheumatologist within 3, 6 and 12 months of suspected diagnosis by a primary care physician.](bmjopen2013003888f02){#BMJOPEN2013003888F2}

[Table 2](#BMJOPEN2013003888TB2){ref-type="table"} compares the characteristics of patients who consulted versus did not consult a rheumatologist within 3 months of cohort entry. More patients who were not seen by a rheumatologist lived in a rural area (19% vs 14%) and remote areas.

###### 

Descriptive characteristics for patients with RA that do and do not receive rheumatology care and influence of various factors on receipt of rheumatology care within 3 months of suspected diagnosis by a primary care physician

  Characteristic                                                                       Seen by a rheumatologist   Multivariate analysis                         
  ------------------------------------------------------------------------------------ -------------------------- ----------------------- --------------------- -----------------------
  Demographics                                                                                                                                                  
   Age, mean (SD)                                                                      53.8 (15.9)                53.6 (16.7)             1.00 (1.00 to 1.00)   1.00 (1.00 to 1.00)
   Male sex, n (%) (REF=female)                                                        3341 (28.6)                2328 (28.9)             1.01 (0.95 to 1.07)   1.04 (0.97 to 1.11)
   Income quintile, n(%) (REF=1---low)                                                 59 (0.5)                   50 (0.6)                REF                   REF
  **  **2                                                                              2197 (18.8)                1693 (21)               1.10 (1.00 to 1.20)   1.08 (0.98 to 1.18)
  **  **3                                                                              2359 (20.2)                1657 (20.5)             1.12 (1.03 to 1.23)   1.11 (1.01 to 1.22)
  **  **4                                                                              2407 (20.6)                1627 (20.2)             1.12 (1.02 to 1.23)   1.09 (0.99 to 1.20)
  **  **5                                                                              2305 (19.7)                1581 (19.6)             1.22 (1.11 to 1.34)   1.18 (1.07 to 1.30)
  Calendar-year of cohort entry (REF=2000)                                                                                                                      
   2000                                                                                1110                       774                     REF                   REF
   2001                                                                                1110                       768                     0.99 (0.87 to 1.13)   0.99 (0.87 to 1.14)
   2002                                                                                1074                       736                     1.00 (0.87 to 1.14)   1.00 (0.87 to 1.15)
   2003                                                                                1154                       830                     0.96 (0.85 to 1.10)   0.99 (0.87 to 1.13)
   2004                                                                                1187                       872                     0.94 (0.83 to 1.08)   0.99 (0.87 to 1.14)
   2005                                                                                1231                       828                     1.05 (0.92 to 1.20)   1.12 (0.98 to 1.28)
   2006                                                                                1179                       782                     1.07 (0.94 to 1.22)   1.13 (0.98 to 1.29)
   2007                                                                                1237                       818                     1.07 (0.94 to 1.23)   1.14 (0.99 to 1.31)
   2008                                                                                1268                       885                     1.01 (0.89 to 1.16)   1.10 (0.96 to 1.26)
   2009                                                                                1144                       773                     1.03 (0.90 to 1.18)   1.10 (0.95 to 1.27)
  Comorbidity: number of Hopkins ADGs in the 2 years prior to entry, n (%) (REF=\<5)                                                                            
   \<5                                                                                 3031 (25.9)                2198 (27.3)             REF                   REF
   5--9                                                                                5802 (49.6)                3988 (49.4)             1.04 (0.97 to 1.12)   1.04 \[0.97 to 1.12\]
   10+                                                                                 2861 (24.5)                1880 (23.3)             1.08 (0.99 to 1.18)   1.07 \[0.98 to 1.17\]
  Hospitalisation for RA prior to rheumatologist visit/end of study period, n(%)       71 (0.6)                   41 (0.5)                1.24 (0.84 to 1.84)   1.34 \[0.89 to 2.02\]
  Geographic                                                                                                                                                    
   Patient rural residence, n(%); (REF=urban)                                          1636 (14.0)                1560 (19.3)             0.70 (0.64 to 0.76)   0.92 (0.83 to 1.01)
   Rheumatology supply per 100 000 adults, mean (SD)                                   1.6 (1.1)                  1.4 (1.0)               1.16 (1.12 to 1.19)   1.35 (1.13 to 1.60)
   Distance to rheumatologist (km), mean (SD)                                          17.8 (64.24)               33.6 (75.89)            n/a                   n/a
   Remote distance (≥100 km to rheumatologist), n(%)                                   312 (2.7)                  735 (9.1)               0.29 (0.25 to 0.34)   0.51 (0.41 to 0.64)
  Primary care physician                                                                                                                                        
   Male sex, n (%) (REF=female)                                                        8069 (69.0)                5803 (71.9)             0.83 (0.77 to 0.89)   0.87 (0.81 to 0.95)
   Years since graduation, mean (SD)                                                   24.3 (10.48)               24.6 (10.53)            1.00 (0.99 to 1.00)   1.00 (0.99 to 1.00)
  Practice type†, n (%) (REF=fee-for-service)                                                                                                                   
   Traditional and enhanced fee-for-service                                            11 085 (94.8)              7699 (95.5)             REF                   REF
   Blended capitation models                                                           609 (5.2)                  367 (4.5)               1.14 (0.98 to 1.32)   1.15 (0.99 to 1.34)

\*Adjusted for all covariates including: patient demographics, clinical factors, primary care physician characteristics, provider continuity and geographic characteristics (including regional variation by regional health service planning areas LHINs not reported here).

†Practice types: *blended capitation models* (FHNs, FHOs, FHTs, an interprofessional team model composed of FHNs and FHOs), *enhanced fee-for-service models* (FHGs and other groups) and *solo fee-for-service practitioners* (those who did not belong to a model).

ADG, Adjusted Diagnostic Groups; FGH, Family Health Group; FHN, Family Health Network; FHO, Family Health Organisation; FHT, Family Health Team; LHIN, Local Health Integration Network; RA, rheumatoid arthritis.

Independent determinants of receiving rheumatology care within 3 months of RA diagnosis are reported in [table 2](#BMJOPEN2013003888TB2){ref-type="table"}. Factors associated with prompt rheumatology care included increasing rheumatology supply (aOR 1.35 (95% CI 1.13 to 1.60)) and higher patient SES (aOR 1.18 (95% CI 1.07 to 1.30)). The strongest independent factor negatively associated with lower frequency of rheumatology visits was for patients who lived at remote distances to rheumatologists (aOR 0.51 (95% CI 0.41 to 0.64)). The likelihood of not having prompt rheumatology consultations was also reduced for patients of male family physicians (aOR 0.87 (95% CI 0.81 to 0.95)). There was no calendar-year effect illustrating an increasing likelihood of seeing a rheumatologist within 3 months over time. However, improvements over time were demonstrated for patients being seen by a rheumatologist within 6 and 12 months ([table 3](#BMJOPEN2013003888TB3){ref-type="table"}).

###### 

Influence of patient demographics, comorbidity, geographic characteristics and primary care physician characteristics on receipt of rheumatology care within 6 and 12 months

  Characteristic                                                             6 months              12 months                                   
  -------------------------------------------------------------------------- --------------------- --------------------- --------------------- -----------------------------
  Demographics                                                                                                                                 
   Age, mean (± SD)                                                          1.00 (1.00 to 1.00)   1.00 (1.00 to 1.00)   1.00 (1.00 to 1.00)   1.00 (1.00 to 1.00)
   Male sex (REF=female)                                                     0.97 (0.90 to 1.04)   0.98 (0.91 to 1.06)   0.92 (0.85 to 1.00)   0.94 (0.86 to 1.02)
  Income quintile (REF=1---low)                                              REF                   REF                   REF                   REF
   2                                                                         1.15 (1.04 to 1.27)   1.14 (1.03 to 1.26)   1.07 (0.96 to 1.21)   1.06 (0.94 to 1.20)
   3                                                                         1.22 (1.10 to 1.35)   1.20 (1.08 to 1.33)   1.17 (1.04 to 1.32)   **1.16 (1.03** to **1.31)**
   4                                                                         1.15 (1.04 to 1.27)   1.11 (1.00 to 1.24)   1.15 (1.02 to 1.30)   1.12 (0.99 to 1.27)
   5                                                                         1.30 (1.17 to 1.44)   1.26 (1.13 to 1.40)   1.35 (1.19 to 1.53)   **1.31 (1.15** to **1.49)**
  Calendar-year of cohort entry (REF=2000)                                   REF                   REF                   REF                   REF
   2001                                                                      1.07 (0.92 to 1.23)   1.07 (0.92 to 1.24)   1.13 (0.96 to 1.34)   1.13 (0.95 to 1.35)
   2002                                                                      1.12 (0.97 to 1.30)   1.12 (0.96 to 1.31)   1.12 (0.95 to 1.33)   1.14 (0.95 to 1.36)
   2003                                                                      1.19 (1.02 to 1.38)   1.22 (1.04 to 1.42)   1.18 (0.99 to 1.40)   1.21 (1.01 to 1.44)
   2004                                                                      1.01 (0.87 to 1.17)   1.04 (0.89 to 1.21)   0.97 (0.82 to 1.15)   1.01 (0.84 to 1.20)
   2005                                                                      1.15 (1.00 to 1.34)   1.21 (1.04 to 1.41)   1.22 (1.02 to 1.45)   1.30 (1.08 to 1.56)
   2006                                                                      1.25 (1.07 to 1.45)   1.30 (1.11 to 1.52)   1.28 (1.07 to 1.53)   1.33 (1.10 to 1.60)
   2007                                                                      1.29 (1.11 to 1.50)   1.37 (1.17 to 1.60)   1.33 (1.11 to 1.59)   1.42 (1.18 to 1.72)
   2008                                                                      1.26 (1.09 to 1.47)   1.35 (1.16 to 1.58)   1.30 (1.09 to 1.55)   1.41 (1.17 to 1.70)
   2009                                                                      1.42 (1.21 to 1.66)   1.49 (1.26 to 1.76)   1.83 (1.51 to 2.22)   1.96 (1.60 to 2.40)
  Comorbidity                                                                                                                                  
   Number of Hopkins ADGs (REF≤5)                                            REF                   REF                   REF                   REF
    5--9                                                                     1.02 (0.94 to 1.10)   1.03 (0.95 to 1.12)   1.03 (0.94 to 1.13)   1.07 (0.97 to 1.18)
    10+                                                                      1.02 (0.93 to 1.12)   1.05 (0.95 to 1.16)   1.04 (0.93 to 1.16)   1.09 (0.97 to 1.23)
  Hospitalisation for RA prior to rheumatologist visit/end of study period   0.60 (0.42 to 0.85)   0.63 (0.44 to 0.91)   0.51 (0.36 to 0.71)   0.54 (0.38 to 0.76)
  Geographic                                                                                                                                   
   Patient rural residence (REF=urban)                                       0.74 (0.68 to 0.81)   1.00 (0.89 to 1.11)   0.80 (0.72 to 0.89)   1.09 (0.96 to 1.24)
   Rheumatology supply per 100 000 adults                                    1.15 (1.11 to 1.20)   1.19 (0.97 to 1.45)   1.16 (1.11 to 1.22)   1.25 (0.98 to 1.61)
   Remote distance (≥100 km to rheumatologist)                               0.28 (0.24 to 0.33)   0.46 (0.36 to 0.59)   0.26 (0.22 to 0.31)   0.33 (0.26 to 0.43)
  Primary care physician                                                                                                                       
   Male sex (REF=female)                                                     0.81 (0.74 to 0.89)   0.89 (0.81 to 0.97)   0.81 (0.73 to 0.90)   0.91 (0.81 to 1.01)
   Years since graduation                                                    1.00 (0.99 to 1.00)   0.99 (0.99 to 1.00)   1.00 (0.99 to 1.00)   0.99 (0.99 to 1.00)
  Practice type†(REF=fee-for-service)                                                                                                          
   Capitation model                                                          1.22 (1.01 to 1.47)   1.13 (0.93 to 1.36)   1.22 (0.99 to 1.51)   1.09 (0.87 to 1.35)

\*Adjusted for all covariates including: patient demographics, clinical factors, primary care physician characteristics, provider continuity and geographical characteristics (including regional variation by regional health service planning areas LHINs not reported here).

†Practice types: *blended capitation models* (FHNs, FHOs, FHTs, an interprofessional team model composed of FHNs and FHOs), *enhanced fee-for-service models* (FHGs and other groups) and traditional *fee-for-service.*

ADG, Adjusted Diagnostic Groups; FGH, Family Health Group; FHN, Family Health Network; FHO, Family Health Organisation; FHT, Family Health Team; LHIN, Local Health Integration Network.

We observed similar associations when we studied the effects of factors on the odds of receiving rheumatology care within 6 and 12 months ([table 3](#BMJOPEN2013003888TB3){ref-type="table"}). The effect of proximity on access became stronger as the time to rheumatology visit was lengthened: 6 months (aOR 0.56 (95% CI 0.36 to 0.59) and 12 months (aOR 0.33 (95% CI 0.26 to 0.43). Patients who were hospitalised for RA subsequent to an initial diagnosis in an outpatient primary care setting were almost half as likely to been seen by a rheumatologist at 6 and 12 months.

Discussion {#s3}
==========

In a publicly funded universal healthcare system, we studied trends in encounters with rheumatologists over the past decade and observed increasing rates of access to rheumatologists within 6 and 12 months after diagnosis by a family physician. However, no such improvements were observed among patients seen within 3 months, a more favourable benchmark. We also explored whether receipt of rheumatology care was associated with patient and family physician characteristics, and measures of rheumatology supply. We found that patients of higher SES were more likely to receive timely rheumatology care, which has also been demonstrated in other Canadian provinces.[@R29] [@R30] Further, proximity to and density of rheumatologists were important determinants of timely rheumatology care.

While our results appear encouraging, 41% of patients are still not seen within 3 months of a primary care diagnosis as recommended by current guidelines. Thus, an important proportion of patients are not receiving optimal care. When interpreting the results it is important to recognise that the delay in rheumatology consultation being studied represents only a proportion of the total delay from the onset of the patients' symptoms. While a previous study reported that the patient delay is very small relative to the family physician delay,[@R31] in our study, it is unknown how long patients have symptoms before seeking medical care, or remain in primary care before their RA is recognised. Therefore, the delays between onset of symptoms to rheumatology care may be larger than that reported here. Conversely, we are also unaware of the disease activity and functional status of the subgroup of patients who do not receive timely rheumatology care within 3 months. Recent data from a large early arthritis clinic indicated that 60% of patients had self-limited symptoms.[@R32] Therefore, a delay of 3 months in receipt of rheumatology care may not always be as deleterious to the likelihood of a good response or remission.[@R33]

Given the high economic impact of RA,[@R34] rheumatologists are key to an integrated healthcare delivery system.[@R35] However, not all patients are receiving the right care at the right time. Delays in timely consultations may reflect the growing burden of RA relative to rheumatology supply. During our study period, the number of rheumatologists in Ontario remained relatively stable (1.5 rheumatologists per 100 000 population).[@R18] [@R36] While most patients with RA were seen by a rheumatologist within 1 year, delays in more timely benchmarks may also be indicative of the need to educate primary care physicians to initiate rheumatology referrals sooner. Ultimately, delays in access to timely quality care and treatment result in increasing disability for patients with RA as well as increasing costs to the healthcare system.[@R34]

Geographical variation in receipt of timely rheumatology care may be indicative of problems with access. Considering the geographical size and features of Ontario, approximately one-quarter of Ontarians reside in communities with 30 000 or fewer residents.[@R37] However, few rheumatologists practice in rural communities.[@R18] Consequently, the threshold for referral to rheumatologists may be higher in remote versus urban communities (ie, rural patients who are referred have substantially more active disease than their urban counterparts).[@R6] [@R36] Thus, there is a need to address the low rheumatology supply among remote communities.

In addition, there was a low likelihood of being seen by a rheumatologist within 6 or 12 months subsequent to a hospital encounter for RA after a patient was initially diagnosed in a primary care setting. In areas with few rheumatologists, family physicians may have no choice but to encourage patients to seek hospital-based specialty care. Also, while most rheumatologists have a hospital appointment, not all hospitals have rheumatologists.[@R38] Thus, our findings reinforce the need for strategies to not only improve access to rheumatologists but also to encourage proper follow-up for these patients.

Our results showed that patients of female family physicians were more likely to receive rheumatology care earlier. While there are conflicting data on the influence of physician gender on practice styles,[@R39] [@R40] female physicians have been shown to engage in more preventive services and to communicate differently with their patients.[@R41] Male physicians may have more confidence in managing RA in primary care, such as starting glucocorticoids prior to rheumatology encounters. Similarly, patients have also reported to have more confidence in male physicians,[@R42] and thus may be more hesitant to seek secondary care. Together, this may explain why patients with RA of female family physicians are more likely to be seen by rheumatologists earlier and that the influence of physician gender was attenuated at 1-year postinitial RA diagnosis.

We also sought to evaluate the influence of primary care models on rheumatology encounters. We hypothesised that patients of capitation models, which involve interdisciplinary teams, allied health providers and where patient enrolment is most strongly encouraged, could improve continuity of care with their patients that could ultimately affect the quality of care that these patients receive. While we found no association, it may be too soon to determine an effect as many physicians changed models over time and few physicians were practising under a capitation model during the study period.[@R43]

Strengths of our study include its large sample and the use of a validated population-based RA cohort.[@R21] Our main limitation is that our cohort definition requires patients to have had their first RA diagnosis code provided by a family physician (ie, those whose physician strongly suspects that the patient has RA). While others have used this approach,[@R9] our analyses are likely restricted to patients with a more homogeneous clinical presentation (such as rheumatoid factor positive patients) or those with more active disease in which the family physician was able to accurately diagnose the condition and/or more likely to use an RA billing code as a reason for visit. Therefore, we may be overestimating the proportion of patients with timely rheumatology encounters. These related caveats are owing to the absence of symptom onset and date of referral in health administrative databases. Future research is required to develop and validate algorithms to better predict RA onset from administrative data. However, previous researchers have also used physician service claims to sample patients with RA from rheumatology practices in order to calculate wait times on a smaller scale, and these studies may be subjected to similar biases (inclusion of early patients with RA with a more homogenous clinical presentation).[@R9] [@R44]

In conclusion, we found increasing access to rheumatologists within 6 and 12 months over time; however, rheumatology encounters within 3 months did not change over time. Measures of poor access negatively impacted rates of encounters with a rheumatologist. Factors that contributed to disparities in rheumatology access included patient SES and physician\'s gender. Strategies to facilitate more timely access, such as improving proximity to and density of rheumatologists along with family physician education on initiating more timely referrals, are acutely needed.
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